Normal human alveolar macrophages have more ability than blood monocytes to produce cell-associated interleukin-1-alpha
- PMID: 2484061
- DOI: 10.1165/ajrcmb/1.6.507
Normal human alveolar macrophages have more ability than blood monocytes to produce cell-associated interleukin-1-alpha
Abstract
Human alveolar macrophages (AM) were obtained by bronchoalveolar lavage from healthy donors, and their abilities to produce extracellular and cell-associated interleukin 1 (IL-1) in response to various activation stimuli were compared with those of autologous blood monocytes. The production of IL-1 alpha and IL-1 beta by monocytes and AM was examined by thymocyte co-stimulation assay and enzyme immunoassays (EIA). Results showed that when activated with lipopolysaccharide (LPS) or desmethyl muramyl dipeptide (norMDP), AM released much less extracellular IL-1 beta than did blood monocytes. In contrast, these activated AM produced more cell-associated IL-1 than did blood monocytes. When the IL-1 activity was examined by the thymocyte assay, the extracellular and cell-associated IL-1 produced by the two cell types were largely IL-1 beta and IL-1 alpha, respectively, as shown by antibody neutralization. The cell-associated IL-1 activity of AM induced by the synergistic actions of suboptimal concentrations of recombinant interferon-gamma (rIFN-gamma) and norMDP was also higher than that of autologous blood monocytes. Consistent with these findings on AM, macrophages generated in vitro by maturation of blood monocytes produced higher levels of cell-associated IL-1 activity than did freshly isolated monocytes. These observations suggest that AM may play a critical role in situ regulation of pulmonary inflammatory and immune reactions through production of cell-associated IL-1 alpha.
Similar articles
-
Induction of membrane-associated interleukin 1 alpha (IL-1 alpha) by synergistic activation of human blood monocytes with interferon gamma and muramyl dipeptide analog.Tokushima J Exp Med. 1989 Dec;36(3-4):97-105. Tokushima J Exp Med. 1989. PMID: 2484023
-
Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producing tumour necrosis factor-alpha and interleukin-1.Eur Respir J. 1992 Feb;5(2):174-81. Eur Respir J. 1992. PMID: 1559582
-
Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.J Immunol. 1986 Feb 1;136(3):1117-22. J Immunol. 1986. PMID: 3079797
-
Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1.J Clin Invest. 1984 Dec;74(6):2208-18. doi: 10.1172/JCI111647. J Clin Invest. 1984. PMID: 6334697 Free PMC article.
-
Differential effects of interleukin-4 on superoxide anion production by human alveolar macrophages stimulated with lipopolysaccharide and interferon-gamma.J Leukoc Biol. 1992 Aug;52(2):218-23. doi: 10.1002/jlb.52.2.218. J Leukoc Biol. 1992. PMID: 1324288
Cited by
-
Suppression by interleukin 4 of activation of human blood monocytes to the tumoricidal state.Jpn J Cancer Res. 1990 Sep;81(9):936-41. doi: 10.1111/j.1349-7006.1990.tb02670.x. Jpn J Cancer Res. 1990. PMID: 2121695 Free PMC article.
-
Interleukin-4 and interferon-gamma inhibit prostaglandin production by interleukin-1beta-stimulated human periodontal ligament fibroblasts.Inflammation. 1999 Feb;23(1):1-13. doi: 10.1023/a:1020231331932. Inflammation. 1999. PMID: 10065757
-
Phenotypic markers of alveolar macrophage maturation in pulmonary sarcoidosis.Lung. 1993;171(5):293-303. doi: 10.1007/BF03215872. Lung. 1993. PMID: 7692188
-
Production of tumor necrosis factor-alpha by alveolar macrophages of lung cancer patients.Jpn J Cancer Res. 1990 Apr;81(4):403-9. doi: 10.1111/j.1349-7006.1990.tb02582.x. Jpn J Cancer Res. 1990. PMID: 2114392 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources